AG
NVO

AmeriFlex Group’s Novo Nordisk NVO Stock Holding History

AmeriFlex Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.7K Buy
1,684
+717
+74% +$30.8K 0.03% 380
2026
Q1 		$35.5K Buy
967
+197
+26% +$9.33K 0.02% 496
2025
Q4 		$39.2K Sell
770
-816
-51% -$41.7K 0.02% 467
2025
Q3 		$88K Sell
1,586
-4,925
-76% -$288K 0.03% 344
2025
Q2 		$441K Buy
6,511
+525
+9% +$35.7K 0.23% 81
2025
Q1 		$416K Buy
5,986
+4,872
+437% +$402K 0.17% 122
2024
Q4 		$94.1K Buy
+1,114
New +$120K 0.04% 310

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

AmeriFlex Group's NVO Position: Q2 2026 in Review

AmeriFlex Group increased its Novo Nordisk (NVO) stake by 74% in Q2 2026, buying an estimated $30.8K and bringing the position to 1,684 shares worth $80.7K. The position accounts for 0.03% of the portfolio, ranked #380.

AmeriFlex Group first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $441K in Q2 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • AmeriFlex Group held 1,684 shares of Novo Nordisk worth $80.7K as of Q2 2026.
  • AmeriFlex Group bought 717 Novo Nordisk shares in Q2 2026, an estimated $30.8K.
  • Novo Nordisk made up 0.03% of AmeriFlex Group's portfolio in Q2 2026, its #380 holding.
  • AmeriFlex Group first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's Novo Nordisk position peaked at $441K in Q2 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.